Paeds SAQs · pain-palliative-and-end-of-life-care
Neuropathic pain in children: SAQ
Short-answer questions on neuropathic pain in children covering the IASP and NeuPSIG definition and grading, the recognition of complex regional pain syndrome and the rehabilitation-first plan, and the cautious off-label use of gabapentin and amitriptyline with their dosing, monitoring, and the limited paediatric evidence base.
On this page & tools
Target exams
This girl has complex regional pain syndrome of the right lower limb. Her pain is disproportionate to the minor twisting injury, which has healed, and she has the characteristic features: allodynia, demonstrated by flinching on light touch and by her description that the bedsocks and bedclothes hurt, hyperalgesia, with the shower water feeling like needles, and regional autonomic and trophic change with the cool, pale, swollen foot. The Mesaroli five-year retrospective review and the broader literature establish that complex regional pain syndrome predominates in adolescent girls and affects the lower limb, and this girl fits that picture exactly. Her normal inflammatory markers and the absence of fever exclude a septic or inflammatory joint, which is the critical exclusion to make before diagnosing complex regional pain syndrome, and her normal structural neurological examination makes a compressive lesion unlikely. On the NeuPSIG grading system her pain is at least possible neuropathic pain, with a neuroanatomic distribution and a plausible injury, and the clinical picture is sufficient to begin the neuropathic plan. [9]
Question 1 (10 marks)
Outline your initial assessment and the foundation of your management plan for this girl, including the diagnosis and how you would exclude dangerous alternatives. [9]
My first task is to confirm the diagnosis and exclude the dangerous alternatives. The diagnosis of complex regional pain syndrome is clinical: severe regional pain disproportionate to any inciting event, accompanied by sensory changes such as allodynia and hyperalgesia, vasomotor changes such as colour and temperature difference, sudomotor changes such as swelling, and motor changes such as a reduced range of movement or dystonia. This girl has all of these, and the Mesaroli review confirms that this presentation in an adolescent girl with lower-limb involvement is the typical paediatric picture. [9]
The single most important alternative to exclude is infection. A warm, swollen, painful limb in a febrile or unwell child is septic arthritis or osteomyelitis until proven otherwise, and complex regional pain syndrome is a diagnosis of exclusion that must never be made in the face of fever or systemic illness. This girl is afebrile and well, and her inflammatory markers and full blood count are normal, which makes infection unlikely, but the exclusion is an active one and I would document the reasoning explicitly. I would also exclude a structural lesion of the nervous system through a deliberate red-flag screen: there is no progressive pain, no focal deficit, no sphincter disturbance, and no systemic features, and the neurological examination is normal, so urgent imaging is not required. The cool, pale limb is the autonomic dysregulation of complex regional pain syndrome, not vascular insufficiency. [9]
The foundation of the management plan is not a drug. The most important single intervention for complex regional pain syndrome is an intensive, function-focused exercise-based rehabilitation programme, and the classic series by Sherry and colleagues demonstrated excellent short- and long-term outcomes with exercise therapy. I would refer her urgently to physiotherapy for a graded programme of desensitisation, weight-bearing, and functional exercise, avoiding immobilisation because rest deepens the disuse and sensitisation that drive the syndrome. I would give a clear, mechanism-based explanation to the girl and her family: the nerve is misfiring and the brain has turned up the gain on the pain, the tissues are not being damaged, and the goal is to retrain the nervous system through movement. [6]
Because she has missed school and is sleeping poorly, I would add psychological support, with cognitive behavioural therapy to reframe the pain, reduce the fear of movement that drives disuse, and address the sleep and mood disturbance that amplify the nervous system's gain. I would quantify her disability with a validated paediatric pain and quality-of-life measure to track her response. I would counsel the family that the goal is a return to function rather than the abolition of pain, that the prognosis with early intensive rehabilitation is excellent, and that I would review her in clinic at two to four weeks with the physiotherapy team. [9]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References5Show ledgerHide ledger
- [1]Finnerup NB, Haroutounian S, Kamerman P, et al Neuropathic pain: an updated grading system for research and clinical practice. Pain, 2016.PMID 27115670
- [3]Cooper TE, Wiffen PJ, Heathcote LC, et al Antiepileptic drugs for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev, 2017.PMID 28779491
- [4]Cooper TE, Heathcote LC, Clinch J, et al Antidepressants for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev, 2017.PMID 28779487
- [6]Sherry DD, Wallace CA, Kelley C, et al Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy. Clin J Pain, 1999.PMID 10524475
- [9]Mesaroli G, Ruskin D, Campbell F, et al Clinical Features of Pediatric Complex Regional Pain Syndrome: A 5-Year Retrospective Chart Review. Clin J Pain, 2019.PMID 31490205